Evidence map›Paper›PMID 35475911›Full record

ArticleJournal of vision2022

Involuntary oculomotor inhibition markers of saliency and deviance in response to auditory sequences.

Oren Kadosh, Yoram S Bonneh

Abstract read
In one paragraph

Article in Journal of vision, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. The Interplay of Bottom-Up Arousal and Attentional Capture during Auditory Scene Analysis: Evidence from Ocular Dynamics.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Oren KadoshSchool of Optometry and Vision Science, Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.
Yoram S BonnehSchool of Optometry and Vision Science, Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our eyes move constantly but are often inhibited momentarily in response to external stimuli (oculomotor inhibition [OMI]), depending on the stimulus saliency, anticipation, and attention. Previous studies have shown prolonged OMI for auditory oddballs; however, they required counting the oddballs, possibly reflecting voluntary attention. Here, we investigated whether the "passive" OMI response to auditory deviants can provide a quantitative measure of deviance strength (pitch difference) and studied its dependence on the inter-trial interval (ITI). Participants fixated centrally and passively listened to repeated short sequences of pure tones that contained a deviant tone either regularly or with 20% probability (oddballs). In an "active" control experiment, participants counted the deviant or the standard. As in previous studies, the results showed prolonged microsaccade inhibition and increased pupil dilation following the rare deviant tone. Earlier inhibition onset was found in proportion to the pitch deviance (the saliency effect), and a later release was found for oddballs, but only for ITI <2.5 seconds. The active control experiment showed similar results when counting the deviant but longer OMI for the standard when counting it. Taken together, these results suggest that OMI provides involuntary markers of saliency and deviance, which can be obtained without the participant's response.

Indexed as

Auditory PerceptionEye MovementsAcoustic StimulationAttentionHumansInhibition, Psychological

Identifiers

PMID35475911
PMCPMC9055552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.